This HTML5 document contains 124 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
phttp://www.wikidata.org/prop/
wikibasehttp://wikiba.se/ontology#
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://dx.doi.org/10.1002/
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q53671407
rdf:type
wikibase:Item
schema:description
artikulong pang-agham tieteellinen artikkeli vedecký článok scientific article published on 2 February 2012 wissenschaftlicher Artikel article scientific 2012年學術文章 bài báo khoa học επιστημονικό άρθρο artigo científico научни чланак научни чланак vetenskaplig artikel 2012年学术文章 научна статия სამეცნიერო სტატია 2012年學術文章 artykuł naukowy מאמר מדעי bilimsel makale article científic 2012년 논문 2012 թվականի փետրվարի 2-ին հրատարակված գիտական հոդված videnskabelig artikel scientific article published on 2 February 2012 artikel ilmiah 2012年學術文章 2012年学术文章 artikull shkencor 2012年の論文 artículo científico publicado en 2012 vitenskapelig artikkel artigo científico articol științific 2012年学术文章 wetenschappelijk artikel scienca artikolo article scientifique наукова стаття, опублікована в лютому 2012 ২ ফেব্রুয়ারি ২০১২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ scientific article published on 2 February 2012 2012年学术文章 2012年學術文章 naučni članak 2012年學術文章 vitskapeleg artikkel artigo científico 2012 nî lūn-bûn مقالة علمية نشرت في 2 فبراير 2012 tudományos cikk vědecký článek 2012年学术文章 научная статья teaduslik artikkel 2012年学术文章 artículu científicu articolo scientifico บทความทางวิทยาศาสตร์ мақолаи илмӣ
p:P577
wds:Q53671407-7D315425-F446-4ED0-ABE5-426E0929ECB6
wdt:P577
2012-02-02T00:00:00Z
p:P2860
wds:Q53671407-9F0F9D5B-34FE-4357-97DE-C9F51EFD1E01 wds:Q53671407-8F7E8FD7-25A3-4B32-A3EE-A837472393FF wds:Q53671407-94D7F611-8F35-4242-9B24-9E430786AE86 wds:Q53671407-98439301-9ADA-4E84-B1FA-38415D14024B wds:Q53671407-9B92EE85-0935-47D5-A6B5-57D8F8AFF4EC wds:Q53671407-FF60C2D1-3BDB-4113-8D2D-34332C56A1DD wds:Q53671407-EFD17974-0247-465A-A5EB-26694C5D73D4 wds:Q53671407-113E49D4-0411-46A2-8E01-0C6B34A48189 wds:Q53671407-19A98CCA-D70B-4CE0-8BA3-ED79D57ECC0F wds:Q53671407-20B03227-3D5D-466E-B59E-07AD47EA7D13 wds:Q53671407-2546A6F7-841B-4A82-8827-410D9C9FE22F wds:Q53671407-0AD4DA15-C7B2-43DE-BAD1-4CC5E2962ACF wds:Q53671407-0F02F94F-582E-4170-86E3-DEB8B474A7B3 wds:Q53671407-8062CC5A-E3BE-4251-8030-7F62F0F24196 wds:Q53671407-2E799572-4956-43CE-8B20-D6D3B8013488 wds:Q53671407-2F329DB0-7AE6-49D5-B300-2C8B115BDB39
wdt:P2860
wd:Q28210235 wd:Q35169892 wd:Q35895164 wd:Q43932784 wd:Q52712844 wd:Q53434763 wd:Q43003756 wd:Q43543039 wd:Q37098607 wd:Q52278029 wd:Q35011085 wd:Q43942991 wd:Q28195528 wd:Q35582776 wd:Q52730190 wd:Q58464315
p:P2093
wds:Q53671407-311AF0A2-B5FE-4657-85A2-398F22AC0A53 wds:Q53671407-39D883BB-410D-4D85-AF59-3489C8D53751
wdt:P2093
Sigrid Behr Walter Schill
rdfs:label
Does additional confounder information alter the estimated risk of bleeding associated with phenprocoumon use--results of a two-phase study. Does additional confounder information alter the estimated risk of bleeding associated with phenprocoumon use--results of a two-phase study.
skos:prefLabel
Does additional confounder information alter the estimated risk of bleeding associated with phenprocoumon use--results of a two-phase study. Does additional confounder information alter the estimated risk of bleeding associated with phenprocoumon use--results of a two-phase study.
schema:name
Does additional confounder information alter the estimated risk of bleeding associated with phenprocoumon use--results of a two-phase study. Does additional confounder information alter the estimated risk of bleeding associated with phenprocoumon use--results of a two-phase study.
p:P50
wds:Q53671407-C704C65A-231D-4265-8A0C-7B6199251B71
wdt:P50
wd:Q21262337
p:P1476
wds:Q53671407-FF212555-0FD1-4E03-ACA5-437268ABD23E
wdt:P1476
Does additional confounder information alter the estimated risk of bleeding associated with phenprocoumon use--results of a two-phase study
p:P304
wds:Q53671407-3411DB01-521C-4CDF-BD71-A055BD316E33
wdt:P304
535-545
p:P31
wds:Q53671407-DBDDC64A-2C6F-45CA-A260-AFC27E40364F
wdt:P31
wd:Q13442814
p:P698
wds:Q53671407-AF08A844-E027-43C4-BC4F-E7145CC42580
wdtn:P698
n11:22302384
wdt:P698
22302384
p:P1433
wds:Q53671407-F02CB9CB-E7FD-40F6-8120-6C11B5EC8331
wdt:P1433
wd:Q15759496
p:P433
wds:Q53671407-F42A7575-B806-470C-939A-606A92CBC64A
p:P478
wds:Q53671407-87F2E865-FED5-4F7D-92D2-7A66063B714F
wdt:P433
5
wdt:P478
21
p:P356
wds:Q53671407-D77D9354-D39D-4822-B9EF-A1A5CFD1A7C5
wdtn:P356
n12:PDS.3193
wdt:P356
10.1002/PDS.3193